Columvi achieved a 78.3% complete response rate and 85% overall response rate in relapsed/refractory mantle cell lymphoma patients. Cytokine release syndrome occurred in 70% of patients, with lower ...
Atezolizumab showed modest response rates in NSCLC patients previously treated with PD-1 inhibitors, with a suggested baseline response rate of 10% for new ICI combinations. The study's primary ...
In today’s crowded marketing landscape, getting and holding attention is harder than ever. Marketers are juggling email, social, paid search, video, and more, each with its own metrics, costs, and ...
Role of induction chemotherapy in locally advanced oropharyngeal carcinoma in Indian population. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a ...
Rina-S showed a 50% confirmed response rate in heavily pretreated advanced endometrial cancer patients, with two complete responses observed. The phase 1/2 results support Rina-S as a potential ...
BARCELONA — Restarting an anti-CGRP monoclonal antibody (mAb) for migraine prevention after a gap in treatment often leads to a lower efficacy rate in the second treatment period, a new study suggests ...
Zongertinib shows a 71% response rate and 12.4 months median progression-free survival in HER2-mutated NSCLC, with minimal adverse events. Patient-reported outcomes indicate rapid improvement in ...
Xilio Therapeutics reports 26% response rate for vilastobart and atezolizumab in metastatic MSS CRC patients, with favorable safety profile. Xilio Therapeutics has reported promising results from its ...
Having shaped outreach strategies for various brands, I’ve seen automation transform sales into a science. Automation amplifies your reach, but it’s not a set-it-and-forget-it solution. High response ...
Who Is Going to Be Next to Donate $1,776 to Our July 4 Fundraiser? The Roe v. Wade of Birthright Citizenship Trad Schism, Again New York Times Story Features ‘Tree Rights’ Audio By Carbonatix Trump is ...
Suggested Citation: "6 Self-Response to the Census." National Academies of Sciences, Engineering, and Medicine. 2023. Assessing the 2020 Census: Final Report. Washington, DC: The National Academies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results